Digoxin Use and Subsequent Clinical Outcomes in Patients With Atrial Fibrillation With or Without Heart Failure in the ENGAGE AF‐TIMI 48 Trial

BACKGROUND: Digoxin is widely used in patients with atrial fibrillation despite the lack of randomized controlled trials. Observational studies report conflicting results regarding its association with mortality, perhaps because of residual confounding by the presence of heart failure (HF). METHODS...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Am Heart Assoc
Autors principals: Eisen, Alon, Ruff, Christian T., Braunwald, Eugene, Hamershock, Rose A., Lewis, Basil S., Hassager, Christian, Chao, Tze‐Fan, Le Heuzey, Jean Yves, Mercuri, Michele, Rutman, Howard, Antman, Elliott M., Giugliano, Robert P.
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2017
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5586309/
https://ncbi.nlm.nih.gov/pubmed/28666993
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.117.006035
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars